SANOFICONRSanofi Consumer Healthcare India Limited
Convert to ideaPharmaceuticals & Biotechnology · Pharmaceuticals
The verdict combines business quality, price and timing. Sign in free to see it.
Sign in freeDown 0.5 this quarter.
Momentum from moving averages, Supertrend and RSI.
Valuation Metrics
Q2 FY2027Intrinsic value, Graham number and DCF against today's price
Forensic screen of the latest filings
Quality, growth, balance sheet and earnings quality behind the score
ⓘ Based on fundamental & forensic analysis. Always verify against official filings and consult a financial advisor.
Financial Metrics
Comparing Q2 FY2027 vs Q2 FY2026
| Quarter | Revenue | Net Profit | OPM | NPM | EPS | Int. Cover |
|---|---|---|---|---|---|---|
| Q2 FY2027 | ₹263 Cr | ₹77 Cr | 37.48% | 29.11% | ₹33.26 | Negligible |
| Q1 FY2027 | ₹236 Cr | ₹69 Cr | 36.49% | 29.19% | ₹29.87 | Negligible |
| Q4 FY2026 | ₹229 Cr | ₹68 Cr | 37.35% | 29.58% | ₹29.44 | 182.4x |
| Q3 FY2026 | ₹251 Cr | ₹67 Cr | 34.42% | 26.49% | ₹28.87 | 182.0x |
| Q2 FY2026 | ₹234 Cr | ₹63 Cr | 34.93% | 26.89% | ₹27.31 | 141.2x |
| Q1 FY2026 | ₹221 Cr | ₹61 Cr | 30.42% | 27.48% | ₹26.36 | 158.8x |
Momentum score, 1-year chart, moving averages, support and resistance.
Turnaround stage, and how each measure moved over 3 years against the company's own range.
Order wins, capex, pledges, rating actions and every material filing.
Management guidance, Q&A highlights and whether they delivered what they said.
The earnings call read across investor dimensions.
Promoter, FII and mutual fund holding, and what changed this quarter.
Similar-size peers in Pharmaceuticals
Compare with peers →Sanofi Consumer Healthcare India Limited operates as a fast-moving consumer healthcare company in India. It offers products in the allergy, physical wellness, and pain care segments under brands, such as Allegra, Combiflam, Avil, DePURA, Festal, and Novalgin NU through distributors, wholesalers, government institutions and hospitals, pharmacies, pharmacy chains, and e-commerce. The company was incorporated in 2023 and is based in Mumbai, India. Sanofi Consumer Healthcare India Limited is a subsidiary of Opella Healthcare Participations B.V.
Note: This comprehensive analysis combines technical data, fundamental data, and investment thesis. Always do your own research and consider your personal risk tolerance before investing.